Stock XOMA XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus XOMA Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq
Other stock markets
 01:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
26.5 USD +4.29% Intraday chart for XOMA Corporation +2.63% +43.24%
01:31pm Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target MT
03/04 XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. CI

Evolution of the average Target Price on XOMA Corporation

Price target over the last 5 years

History of analyst recommendation changes

d11065008a369f253c7698bd96f8182.vrzPzhkKX2voHczRRlEMRlE4wLYsNjcuG_64_83TyUE.946oilVcEz-Kb5iSPDNlLhx9tv4Vcg5BdJXPkaKLhzL7xqasWycxX7Furw~2e67972e63865326b34cacad2c5259ee

Analyst Recommendations on XOMA Corporation

Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target MT
HC Wainwright Adjusts Price Target on XOMA to $74 From $69, Maintains Buy Rating MT
XOMA : Wedbush Suspended Coverage on XOMA MT
XOMA : HC Wainwright Adjusts XOMA's Price Target to $69 from $56, Keeps Buy Rating MT
XOMA : Aegis Capital Adjusts XOMA Price Target to $56 From $60, Maintains Buy Rating MT
Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Aegis Capital Starts XOMA at Buy with $20.68 Price Target MT
XOMA : Wedbush Adjusts XOMA's Price Target to $41 From $36, Citing Iscalimab, Cetrelimab Projections; Outperform Rating Kept MT
XOMA : Wedbush Adjusts XOMA's Price Target to $36 From $29 on Vicineum Sales Forecast, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
25.41 USD
Average target price
57 USD
Spread / Average Target
+124.32%
High Price Target
74 USD
Spread / Highest target
+191.22%
Low Price Target
40 USD
Spread / Lowest Target
+57.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering XOMA Corporation

HC Wainwright
Wedbush
Aegis Capital

Ratings for XOMA Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. Consensus XOMA Corporation